Overview

A Survey on Efficacy and Safety in Patients With Endometriosis

Status:
Completed
Trial end date:
2017-10-13
Target enrollment:
Participant gender:
Summary
This survey is intended to collect efficacy and safety data of Duphaston® Tablets in patients with endometriosis under actual condition of its use and to obtain data for effectively and safely utilizing this drug.
Details
Lead Sponsor:
Mylan Inc.
Treatments:
Dydrogesterone